Minnesota House Bill HF120

Minnesota 2025-2026 Regular Session

• Introduced: 2/10/25
• Refer: 2/10/25

Caption

Intensive comprehensive law enforcement education and training program modified, and money appropriated.

Summary

HF120 would require prepaid health plans and county-based purchasing plans that provide prescription drug coverage under Minnesota Medical Assistance and MinnesotaCare to pay pharmacies a dispensing fee for each prescribed drug they dispense. The required fee must be at least the amount already set in Minnesota law for fee-for-service Medicaid pharmacy dispensing under section 256B.0625, subdivision 13e, paragraph (a). The bill also preserves the state’s existing authority to modify managed care prescription drug coverage to increase rebate savings and manage utilization through tools such as preferred drug lists and prior authorization. The bill is tied to federal approval and would take effect on January 1, 2026, or later if federal approval is delayed. It amends Minnesota Statutes section 256B.69, subdivision 6d, which governs prescription drugs in prepaid managed care contracts, and would directly affect managed care organizations, county-based purchasing plans, pharmacies, and the state’s Medical Assistance program administration.

Impact

This bill would change Minnesota’s managed care Medicaid rules by adding a minimum pharmacy dispensing-fee requirement for health plan companies and county-based purchasing plans that cover prescription drugs for eligible persons under chapters 256B and 256L. It would align managed care pharmacy reimbursement more closely with the dispensing fee already paid in the fee-for-service program, potentially increasing pharmacy payments and plan costs while affecting how managed care contracts are structured and administered. Because the change is contingent on federal approval, implementation depends on federal Medicaid authorization.

Sentiment

The available record shows no committee transcript, vote tally, or recorded debate, so there is no direct evidence of support or opposition in the materials provided. Based on the bill text, the measure appears designed to address pharmacy reimbursement concerns while preserving state cost-management tools in managed care. The absence of recorded votes or discussion prevents a reliable assessment of broader legislative sentiment.

Contention

The main policy tension is between pharmacy reimbursement and managed care cost control. Pharmacies are likely to favor the bill because it guarantees a minimum dispensing fee in managed care, while health plans and county-based purchasing plans may object to the added cost and reduced flexibility in setting pharmacy payment rates. Another potential point of contention is the bill’s interaction with federal Medicaid approval, since implementation depends on federal sign-off and managed care contract changes.